(19)
(11) EP 3 030 303 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
09.06.2021 Bulletin 2021/23

(45) Mention of the grant of the patent:
05.05.2021 Bulletin 2021/18

(21) Application number: 14835244.6

(22) Date of filing: 05.08.2014
(51) International Patent Classification (IPC): 
A61M 16/06(2006.01)
(86) International application number:
PCT/NZ2014/000158
(87) International publication number:
WO 2015/020535 (12.02.2015 Gazette 2015/06)

(54)

INTERFACE

SCHNITTSTELLE

INTERFACE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 05.08.2013 US 201361862236 P
17.06.2014 US 201462013417 P

(43) Date of publication of application:
15.06.2016 Bulletin 2016/24

(60) Divisional application:
21164690.6

(73) Proprietor: Fisher & Paykel Healthcare Limited
East Tamaki, Auckland 2013 (NZ)

(72) Inventors:
  • PATEL, Roheet
    Auckland 2013 (NZ)
  • BEARNE, Peter David Alexander
    Auckland 2013 (NZ)
  • COX, Michael John Henri
    Auckland 2013 (NZ)
  • MASHAL, Fadi Karim Moh'd
    Auckland 2013 (NZ)
  • MIDDELKOOP, Kirstin Elizabeth
    Auckland 2013 (NZ)

(74) Representative: Forresters IP LLP 
Skygarden Erika-Mann-Straße 11
80636 München
80636 München (DE)


(56) References cited: : 
EP-A1- 2 130 563
WO-A1-2004/071565
WO-A1-2006/130903
WO-A1-2012/040791
WO-A1-2013/142909
WO-A1-2014/045136
WO-A1-2014/062070
WO-A2-2013/128324
US-A1- 2011 308 526
US-A1- 2012 080 035
 WO-A1-2004/071565
WO-A1-2005/063328
WO-A1-2010/067235
WO-A1-2013/066195
WO-A1-2014/021722
WO-A1-2014/062070
WO-A2-2013/128324
US-A1- 2004 182 396
US-A1- 2011 308 526
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).